Plasma levels of local anaesthetics following their injection are affected by many factors. Serial plasma levels following injection of lignocaine and prilocaine at various rates in over 500 patients have been measured and this has allowed some of these factors to be assessed and quantified. The vascularity of the site of injection causes major differences in the maximum plasma level. Prilocaine consistently gives lower levels than lignocaine. Adrenaline causes a reduction in the plasma levels of both drugs and the optimal concentration is 1:200,000. Speed of injection is important when giving the drugs intravenously but not epidurally. The concentration of the injected solution does not affect the plasma levels. The weight and age of the patients (all adult females) were unrelated to the mayi'mnm plasma levels.
The measurement of plasma levels of local anaesthetic drugs has become increasingly used in the last few years. This is because of the close relationship between the systemic blood level and the toxic effects of the drugs. Moreover, when these drugs are used as anti-arrhythmic agents, their therapeutic effect is also correlated with the plasma level.
To be meaningful, a plasma level must approximate to the tissue level in the target organs, e.g. the brain or the myocardium. Thus mechanisms, such as protein binding, which lead to high plasma levels and low tissue levels must be minimal Work done in animals with 14 C labelled lignocaine and prilocaine (Akerman et al., 1966, and Katz, 1968) would indicate that brain and myocardial levels closely follow the decay curve of the drugs in the blood. Therefore, useful conclusions can be drawn from knowledge of the blood level, remembering that the ratio of the levels in plasma, brain and myocardium is approximately 1:4:5.
In man, it is generally accepted that toxic effects from lignocaine occur in conscious subjects at a plasma level in excess of 5 /"g/ml (Foldes et al., 1960) . Anaesthetized patients, however, do not show signs of toxicity until a level of 10 /ig/ml is reached when circulatory depression becomes obvious (Bromage and Robson, 1961) . There is evidence that this is also true of prilocaine (Englesson et al., 1962) . For an anti-arrhythmic effect of lignocaine on the myocardium, venous levels in excess of 1-2 /ig/ml are required (Killip, 1968) , though this effect increases with the plasma level up to 10 /*g/ml.
The plasma level of a drug is the resultant of absorption, distribution and elimination. It is now established that lignocaine is distributed according to a two compartment model in man (Boyes et al., 1971) . Following absorption from the site of injection, the drug is rapidly distributed into those tissues which achieve fast equilibration. Following this a redistribution takes place into other tissues which reach equilibration much more slowly. This sequence of events is illustrated diagrammatically in figure 1. Local anaesthetics which are not esters (i.e. all those in common use except procaine and amethocaine (tetracaine)) are degraded in the liver, less than 5 per cent being eliminated unchanged. Harrison and Alderman (1971) have shown that, on average, 70 per cent of lignocaine is removed from the blood reaching the liver in one circulation through the liver. Thus, in patients with a low hepatic blood flow, high systemic plasma levels of lignocaine are achieved.
The main factors which might affect the plasma levels of local anaesthetics are: (a) Site of injection; (b) Drug used; (c) Addition of adrenaline; (a) Concentration of drug; (e) Speed of injection; (J) Dosage of drug; (g) Weight of patient; (h) Age of patient; (i) Speed of elimination.
In order to quantify these factors, we have studied a large number of patients (over 500), dividing them into groups which differ from other groups by only one factor. Details of the methodology and results from the earlier series have already been published (Braid and Scott, 1965, 1966) . Serial blood samples were withdrawn at 5, 10, 15, 20, 30 and 60 min after injection of the local anaesthetic. Groups of patients were compared either by comparison of the mean plasma levels at each time of sampling, or by comparison of the mean of the maximum level reached in each patient without regard to time. The maximum level in all patients occurred within 30 min of injection, the great majority occurring between 10 and 20 min
The plasma lignocaine and prilocaine levels were measured colorimetrically (Woods et al., 1951) . The results obtained with this method have been checked by gas chromatography which is now a much more convenient method of determining plasma levels. However, it was decided to continue to use the colorimetric method so as not to change the procedure part way through the investigation. As the period concerned covered several years, the method was further checked by repeating two of the earlier series four years later. In both these there was no detectable difference between the results.
In determining plasma levels of local anaesthetics it should always be stated exactly what is being injected and what is being measured. Too often it is not clear whether the doses given and the levels determined are in terms of the local anaesthetic base, the anhydrous hydrochloride form or the hydrochloride salt. Thus 1 g of lignocaine hydrochloride BP is equivalent to 0.938 g of lignocaine hydrochloride anhydrous or 0.811 g of lignocaine base.
The situation is further confused by a difference between the BP and the USP formulations, the former being in terms of the hydrochloride salt and the latter in terms of the hydrochloride anhydrous form, Le., there is approximately 6 per cent less lignocaine in the BP form.
In the data presented below all doses and plasma levels refer to lignocaine hydrochloride BP and prilocaine hydrochloride. All plasma levels are in terms of lignocaine base or prilocaine base. Values shown in the tables are mean mavimiim values with SEM.
Site of injection.
Four sites of injection were chosen, involving the following techniques.
(1) Intercostal block: This involved ten intercostal nerves (five on each side) to provide muscular relaxation during abdominal surgery. It consisted, therefore, cf multiple intramuscular injections.
(2) Lumbar epidural block.
(3) Subcutaneous vaginal injection: This was used during vaginal operations and care was taken to avoid accidental intravenous injection by constant movement of the needle.
(4) Subcutaneous abdominal injection.
The results are shown in fig. 2 and table I. It will be seen that the highest levels were obtained with intercostal block followed by subcutaneous vaginal, epidural and subcutaneous abdominal injection. The differences between the sites of injection are highly significant (P<0.001) except when comparing epidural with subcutaneous vaginal injection. It is evident that the plasma level is related to the vascularity of the injection site, higher levels being reached more quickly in the more vascular sites. The comparatively low figures seen with epidural block are surprising as it is generally considered that the epidural space is highly vascular. It has been pointed out before, however (Braid and Scott, 1966) , that the vessels within the epidural space are not supplying structures within that space. The number of capillaries (from which absorption mainly takes place) is minimal
Drug used.
Of the two drugs tested prilocaine was always associated with significantly lower plasma levels than with lignocaine (table II and fig. 3 ). The reason for this would appear to be mainly explained by differences in distribution and metabolism. When considering plasma levels of these drugs it should be remembered that there is a slightly different plasma/ erythrocyte concentration. Thus, with lignocaine, the plasma/erythrocyte concentration ratio is 1:0.8; with prilocaine it is 1:1.2. However, the reduction in plasma levels obtained with prilocaine (around 35 per cent) would indicate that it is a significantly less toxic drug. 
Addition of adrenaline.
Adrenaline, by causing local vasoconstriction, should delay the absorption of the local anaesthetic. At many injection sites this is true ( fig. 4 and table HI). However, the amount by which blood levels are reduced when the drug is combined with adrenaline varies considerably, and three points should be considered.
(1) The site of injection: Adrenaline may have a better localizing effect in some areas than in others.
(2) The concentration of adrenaline.
(3) The drug used: Local anaesthetics vary according to the degree by which they themselves cause vasodilatation. Adrenaline will have more effect with those drugs that cause the greatest vasodilatation. The effect of adrenaline at different sites of injection is shown in fig. 4 . Subcutaneous injection, regardless of tissue vascularity, is most affected by adrenaline, a reduction of plasma concentration by 50 per cent occurring when it is added. Intercostal block appears least affected and this may be attributable to the normal physiological response of muscle vessels to adrenaline, i.e., vasodilatation. When injected locally, however, the concentration of adrenaline will be much higher than that occurring physiologically and some degree of vasoconstriction will occur, though this is likely to be less intense than at other sites.
The concentration of adrenaline that should be added to solutions has been argued for many years and the recommendations have varied from 1:80,000 to 1:400,000. Our results show that only rarely is 1:80,000 superior to 1:200,000 ( fig. 5 and table IV), and that 1:400,000 cannot be distinguished from plain solutions ( fig. 6 and table V).
Generally speaking, lignocaine is more affected by adrenaline than prilocaine in epidural block (fig .  7 and table VI) . This, however, may not be the In summary it would appear that adrenaline is most effective subcutaneously, that the optimum concentration is 1:200,000, and that it is more effective with lignocaine than prilocaine. 
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Concentration of solution.
It has for many years been accepted that increasing the concentration of solution increases the toxicity of local anaesthetics. When blood levels, following the administration of various solutions, are compared, however, it is obvious that, in the clinical range, increasing the concentration does not increase the maximum blood level if the dosage is kept constant ( fig. 9, 
Speed of injection.
In certain procedures it is possible to vary considerably the speed of injection. Two series of epidural block are compared, one receiving the drug, in 60 seconds and the other in 15 seconds. The results are shown in fig. 10 and table VIII. Rapidinjection resulted in plasma levels slightly higher than the slower injection, although the maximum levels did not differ significantly.
When considering the intravenous route, however, the speed of injection is much more critical, 
Rapid injection Normal injection ----
It is now possible to say that, in the concentrations and dosages used in anaesthesia, the concentration of the drug does not alter toxicity provided the dose is kept constant and accidental intravenous injection is avoided. It has recently been shown that with intramuscular injection increasing the concentration up to 10 per cent has no effect on the plasma levels of lignocaine (Jebson, 1971) . especially if a bolus injection is made. This is frequently necessary in the treatment of arrhythmias in patients with myocardial infarction. In patients with a low cardiac output not only will the plasma levels reached be higher (on account of the smaller amount of blood in which the dose is mixed in the first circulation) but the brain and myocardium will receive a larger proportion of that output than in normal circumstances. Harrison and Alderman (1971) have shown that much higher plasma levels are reached in cases of low cardiac output. Thus even small quantities of lignocaine given rapidly intravenously could cause convulsions and myocardial depression.
Dosage of drug.
It would seem obvious that higher doses of a drug should produce higher blood levels. The important question, however, is whether the relationship between dosage and blood level is linear.
This was tested in epidural block with lignocaine and prilocaine, both with and without 1:200,000 adrenaline ( fig. 11 ). As can be seen the relationships are reasonably linear in the dose range from 200-700 mg with lignocaine and 200-600 mg with prilocaine, such dosage covering the vast majority of local anaesthetic procedures. As all the regression lines fail to cross the y-axis at zero, it must be assumed that the relationship is not linear at doses below 200 mg.
The possibility that the relationship is not truly linear when adrenaline is added to prilocaine has been mentioned above. This would explain the greater difference seen between plain solutions and those with adrenaline at doses of 200 and 600 mg compared with 400 mg.
Weight oj patient.
It is common practice to calculate drug dosage on a mg/kg body weight basis. This assumes that if distribution of die drug occurs evenly in the body then patients of greater mass will achieve lower plasma levels. When our data were put to die test, however, by plotting body weight against maximum plasma level (keeping the dosage in mg constant), no relationship could be seen between the two variables ( fig. 12) . Similarly, no relationship was found between dosage and surface area, or lean body mass calculated from standard formulae. These results would indicate that the distribution space for lignocaine was much more constant from patient to patient than was body weight. It is important to remember that all the subjects in die comparison were female adults whose differences in body weight were mainly related to differences in adipose tissue. Thus a woman might, over the course of years, double her body weight without affecting her distribution volume of lignocaine.
Aldiough diere must be differences between subjects whose body weights, excluding fat, are truly different, e.g., children and adults, or males and females, the uncritical application of dosage on a mg/kg basis can be dangerous as it may result in considerable overdosage of obese patients.
Age of patient.
It has been shown that solution injected into the epidural space spread further in more elderly patients (Bromage, 1962) and it might be expected that higher plasma levels would be reached if the absorbing area were larger. When age is plotted against plasma level reached after epidural injection, however, no direct relationship is observed ( fig. 13) figure 12 plotting plasma level against age.
No correlation was found.
Speed of elimination.
As has been mentioned, the liver is responsible for the destruction of lignocaine and prilocaine. Thus liver blood flow is extremely important in regard to the rate at which elimination occurs. It is, therefore, important to remember that in certain states liver blood flow is greatly reduced. These include conditions associated with low cardiac output especially when associated with shock (Harrison and Alderman, 1971 ).
Lignocaine and prilocaine are reasonably safe drugs but, in spite of this, overdosage and fatalities still occur. It is to be hoped, therefore, that increasing knowledge will give the administrator of these drugs the ability to judge the dosage correctly in an individual patient. dental anaesthesia and analgesia have undergone considerable modification in the last twenty years. These changes result from the introduction of new drugs coupled with a new wave of interest and enthusiasm in this previously neglected branch of general anaesthesia. A considerable amount of investigation of currently used drugs and methods has been undertaken recently so that it is now possible to base opinions more on scientific data than on clinical impression, which was hitherto the accepted method of appraisal. Associated with these changes is an alteration in the pattern of dental anaesthesia and analgesia. Thus, patients are now being submitted to more extensive and more prolonged procedures in the dental chair whilst under the influence of centrally acting, as opposed to locally acting, drugs. In order to prevent serious accidents that may occur in dental anaesthesia, wider knowledge of all aspects of anaesthesia is essential. The author and three contributors have set out to produce a book incorporating the relevant basic sciences and practical techniques of modern dental anaesthesia and analgesia.
FACTEURS AFFECT ANT LES TAUX PLASMATIQUES DE LIGNOCAINE ET PRILOCAINE
SOMMAIRE
It is estimated that in the U.S.A. 20 per cent of the four million general anaesthetics given per year for dental procedures are administered by dental practitioners. Furthermore in the past five years 20 per cent of all dentists in the United States have purchased nitrous oxide analgesic machines. The current interest in intravenous and psychosedation techniques has considerably widened the scope of anaesthesia and sedation available to the dental patient. This book will therefore be of great value to those dental surgeons who wish to be more informed about modern agents and techniques. Junior anaesthetists will also find much of interest and importance relating to this particular branch of anaesthesia, in which training is hard to obtain. It is to be hoped that the dental surgeon will not be lulled into a false sense of security, for as the author rightly points out in the introduction, oral surgeons tend to minimize the dangers inherent in anaesthesia and the skill required for its practice.
Dental surgery is obviously very different in the U.S.A. where economic and social factors have a great influence on out-patient practice. Thus, it is extremely doubtful if the advice regarding the management of a patient with haemophilia on an outpatient basis would find acceptance in this country. The section on selection of anaesthesia could be considerably enlarged since there are many common problems on which the dental surgeon requires guidance, such as the management of the patient with diabetes mellitus or epilepsy, which receive little attention. Similarly, the whole problem of dental surgery in the mentally handicapped child, in whom dental procedures so often can only be done under general anaesthesia, receives no mention. No doubt future editions will correct the error which states that tubocurarine can be used as the analgesic part of the triad of balanced anaesthesia.
This well-produced book can be thoroughly recommended to all dental surgeons practising anaesthesia and analgesia and all anaesthetists who wish to obtain more factual information of the effects of general anaesthesia in the dental patient.
G. H. Bush
